|
LOC730101 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.27009530565192E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.47319950577685E-10 |
| Normal-vs-Stage2 |
1.52856999999784E-05 |
| Normal-vs-Stage3 |
3.56326079753444E-12 |
| Normal-vs-Stage4 |
1.64468438867971E-12 |
| Stage1-vs-Stage2 |
4.668400E-01 |
| Stage1-vs-Stage3 |
1.845500E-02 |
| Stage1-vs-Stage4 |
5.93220000000283E-05 |
| Stage2-vs-Stage3 |
5.186200E-02 |
| Stage2-vs-Stage4 |
3.699300E-03 |
| Stage3-vs-Stage4 |
9.860500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.21653856064586E-12 |
| Normal-vs-AfricanAmerican |
4.34380000000623E-05 |
| Normal-vs-Asian |
4.25920000379776E-08 |
| Caucasian-vs-AfricanAmerican |
5.242800E-01 |
| Caucasian-vs-Asian |
1.609170E-01 |
| AfricanAmerican-vs-Asian |
8.895200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80179982045559E-10 |
| Normal-vs-Female |
3.01539904157266E-11 |
| Male-vs-Female |
7.292200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.00349991941584E-10 |
| Normal-vs-Age(41-60Yrs) |
1.22046817097043E-12 |
| Normal-vs-Age(61-80Yrs) |
1.43330003421482E-09 |
| Normal-vs-Age(81-100Yrs) |
8.717500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.343630E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.945200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.436800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.035850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.157800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.553000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.893600E-02 |
| Classical-VS-Follicular |
5.331800E-02 |
| Classical-VS-Other |
6.800800E-01 |
| Classical-VS-Normal |
5.7112981011187E-11 |
| Tall-VS-Follicular |
1.342380E-03 |
| Tall-VS-Other |
5.116200E-01 |
| Tall-VS-Normal |
3.46955797425608E-12 |
| Follicular-VS-Other |
3.423000E-01 |
| Follicular-VS-Normal |
4.92459999446027E-08 |
| Other-VS-Normal |
1.600590E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.55031584528842E-15 |
| Normal-vs-N1 |
2.94231305986159E-12 |
| N0-vs-N1 |
6.386400E-02 |
|
|
